Ray Therapeutics
Series BApr 2026

Series B — Ray Therapeutics

$125.0MRaised

Overview

Organization

Ray Therapeutics

Funding Type

Series B

Additional funding details

Free accounts get 25 credits every month. A funding reveal uses credits.

About Ray Therapeutics

Biotech
Genomics
Therapeutics

Berkeley, United States

View Full Profile